CLCS
CELL SOURCE INCstockOTC
EODNov 17, 2026
0.4295USD+16.065%(+0.0595)250
Loading…
Loading…
18.01M
Healthcare
Biotechnology
HQ
New York, NY, USA
Previous Close
$0.37
Beta
-0.28
52-Week High
$2.25 2026-02-27
52-Week Low
$0.25 2026-08-12
SMA 50
$0.52
SMA 200
$0.65
Avg. Vol 10D
2,573
Avg. Vol 30D
2,568
Avg. Vol 90D
3,255
Relative Vol
0.10
41.94M
54.53M
1,017
0.00%
1.13
915
654
-4.7M
25.58
CLCS Profile
marrow cell source , has been started with the aim to cater to patients who required a matched bone marrow sample. indian gene pool requires a bone marrow registry
CLCS Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 0.44 | 2026-11-10 | -2.39% | 35.649 |
| 1M | 0.49 | 2026-10-19 | -12.04% | 6.718 |
| 3M | 0.65 | 2026-08-17 | -33.71% | 3.173 |
| 6M | 0.84 | 2026-05-19 | -48.87% | 1.060 |
| 1Y | 0.35 | 2025-11-18 | +22.71% | -0.279 |
| 2Y | 0.42 | 2024-11-18 | +3.15% | — |
| 5Y | 1.33 | 2021-11-18 | -67.70% | 8.997 |
CLCS Stock Summary
CELL SOURCE INC (OTC:CLCS) stock price today is $0.43, and today's volume is 250. CLCS is up 16.065% today. The 30 day average volume is 2,568. CLCS market cap is $18.01M with 41.94M shares outstanding.